Centene Corp at Deutsche Bank HealthCare Summit Transcript
Good morning, everybody, and welcome to the DB Healthcare submit. I'm George Hill. I'm the health care technology and services analyst at DB. I cover the MCOs and a bunch of the health care technology stuff. I call it the stuff -- very happy to have with us this morning, Centene, CEO, Sarah London and CFO, Drew Asher.
Good morning, guys. Thanks for coming back. Sarah, you guys reiterated your 2026 guidance this morning I thought I would kick it to you to start. I guess, just talk to us about the reiterated guidance. Any other introductory comments that you want to make -- and then for Sarah, Drew, if there's anything that you want to say as it relates to utilization or the moving pieces or if there's anything different, I would love to hear what you guys have to say to kick it off.
I'm happy to provide a couple of statements on the quarter and then go deeper into any of it. Obviously, reiterated our full year adjusted diluted EPS guidance of greater
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
